These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 9052903)

  • 41. Neurochemical effects of the M1 muscarinic agonist xanomeline (LY246708/NNC11-0232).
    Bymaster FP; Wong DT; Mitch CH; Ward JS; Calligaro DO; Schoepp DD; Shannon HE; Sheardown MJ; Olesen PH; Suzdak PD; Swedberg MD; Sauerberg P
    J Pharmacol Exp Ther; 1994 Apr; 269(1):282-9. PubMed ID: 7909558
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacological approaches to targeting muscarinic acetylcholine receptors.
    Matera C; Tata AM
    Recent Pat CNS Drug Discov; 2014; 9(2):85-100. PubMed ID: 25413004
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of receptor protein and membrane lipids in xanomeline wash-resistant binding to muscarinic M1 receptors.
    Jakubík J; Tucek S; El-Fakahany EE
    J Pharmacol Exp Ther; 2004 Jan; 308(1):105-10. PubMed ID: 14569060
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of muscarinic M
    Stoll K; Hart R; Lindsley CW; Thomsen M
    Psychopharmacology (Berl); 2018 Mar; 235(3):815-827. PubMed ID: 29250738
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of membrane cholesterol in differential sensitivity of muscarinic receptor subtypes to persistently bound xanomeline.
    Randáková A; Dolejší E; Rudajev V; Zimčík P; Doležal V; El-Fakahany EE; Jakubík J
    Neuropharmacology; 2018 May; 133():129-144. PubMed ID: 29407765
    [TBL] [Abstract][Full Text] [Related]  

  • 46. PET study of the M1-agonists [11C]xanomeline and [11C]butylthio-TZTP in monkey and man.
    Farde L; Suhara T; Halldin C; Nybäck H; Nakashima Y; Swahn CG; Karlsson P; Ginovart N; Bymaster FP; Shannon HE; Foged C; Suzdak PD; Sauerberg P
    Dementia; 1996; 7(4):187-95. PubMed ID: 8835881
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The M1/M4 preferring agonist xanomeline is analgesic in rodent models of chronic inflammatory and neuropathic pain via central site of action.
    Martino G; Puma C; Yu XH; Gilbert AK; Coupal M; Markoglou N; McIntosh FS; Perkins MN; Laird JMA
    Pain; 2011 Dec; 152(12):2852-2860. PubMed ID: 22018972
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Normal-phase liquid chromatography-particle-beam mass spectrometry in drug metabolism studies of the dopamine receptor antagonist Odapipam and the muscarine M1 receptor agonist Xanomeline.
    Andersen JV; Hansen KT
    Xenobiotica; 1997 Sep; 27(9):901-12. PubMed ID: 9381731
    [TBL] [